Annual EBIT
-$67.84 M
-$1.04 M-1.55%
31 December 2023
Summary:
Inozyme Pharma annual earnings before interest & taxes is currently -$67.84 million, with the most recent change of -$1.04 million (-1.55%) on 31 December 2023. During the last 3 years, it has fallen by -$10.79 million (-18.92%). INZY annual EBIT is now -485.15% below its all-time high of -$11.57 million.INZY EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$23.15 M
+$2.48 M+9.69%
30 September 2024
Summary:
Inozyme Pharma quarterly earnings before interest & taxes is currently -$23.15 million, with the most recent change of +$2.48 million (+9.69%) on 30 September 2024. Over the past year, it has dropped by -$7.47 million (-47.62%). INZY quarterly EBIT is now -435.97% below its all-time high of -$4.32 million, reached on 30 September 2019.INZY Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$91.08 M
-$7.47 M-8.93%
30 September 2024
Summary:
Inozyme Pharma TTM earnings before interest & taxes is currently -$91.08 million, with the most recent change of -$7.47 million (-8.93%) on 30 September 2024. Over the past year, it has dropped by -$25.85 million (-39.62%). INZY TTM EBIT is now -1663.69% below its all-time high of -$5.16 million, reached on 31 March 2019.INZY TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.6% | -47.6% | -39.6% |
| 3 y3 years | -18.9% | -62.4% | -85.3% |
| 5 y5 years | -485.1% | -436.0% | -548.8% |
INZY EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.8% | at low | -62.4% | +9.7% | -85.3% | at low |
| 5 y | 5 years | -485.1% | at low | -436.0% | +18.2% | -548.8% | at low |
| alltime | all time | -485.1% | at low | -436.0% | +18.2% | -1663.7% | at low |
Inozyme Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.15 M(-9.7%) | -$91.08 M(+8.9%) |
| June 2024 | - | -$25.64 M(+16.4%) | -$83.61 M(+14.9%) |
| Mar 2024 | - | -$22.02 M(+8.7%) | -$72.78 M(+7.3%) |
| Dec 2023 | -$67.84 M(+1.6%) | -$20.26 M(+29.2%) | -$67.84 M(+4.0%) |
| Sept 2023 | - | -$15.69 M(+5.9%) | -$65.23 M(-1.8%) |
| June 2023 | - | -$14.81 M(-13.3%) | -$66.46 M(-0.9%) |
| Mar 2023 | - | -$17.08 M(-3.3%) | -$67.04 M(+0.4%) |
| Dec 2022 | -$66.80 M(+17.9%) | -$17.66 M(+4.4%) | -$66.80 M(-1.6%) |
| Sept 2022 | - | -$16.91 M(+9.9%) | -$67.90 M(+4.1%) |
| June 2022 | - | -$15.39 M(-8.6%) | -$65.25 M(+4.4%) |
| Mar 2022 | - | -$16.84 M(-10.2%) | -$62.51 M(+10.4%) |
| Dec 2021 | -$56.65 M | -$18.76 M(+31.5%) | -$56.65 M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$14.26 M(+12.7%) | -$49.16 M(-22.2%) |
| June 2021 | - | -$12.65 M(+15.3%) | -$63.21 M(+5.2%) |
| Mar 2021 | - | -$10.97 M(-2.7%) | -$60.11 M(+5.4%) |
| Dec 2020 | -$57.04 M(+174.2%) | -$11.27 M(-60.2%) | -$57.04 M(+8.6%) |
| Sept 2020 | - | -$28.32 M(+196.6%) | -$52.54 M(+84.1%) |
| June 2020 | - | -$9.55 M(+20.8%) | -$28.54 M(+21.2%) |
| Mar 2020 | - | -$7.91 M(+16.8%) | -$23.55 M(+13.2%) |
| Dec 2019 | -$20.81 M(+79.5%) | -$6.77 M(+56.7%) | -$20.80 M(+48.2%) |
| Sept 2019 | - | -$4.32 M(-5.1%) | -$14.04 M(+44.5%) |
| June 2019 | - | -$4.55 M(-11.8%) | -$9.72 M(+88.2%) |
| Mar 2019 | - | -$5.16 M | -$5.16 M |
| Dec 2018 | -$11.59 M | - | - |
FAQ
- What is Inozyme Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Inozyme Pharma?
- What is Inozyme Pharma annual EBIT year-on-year change?
- What is Inozyme Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Inozyme Pharma?
- What is Inozyme Pharma quarterly EBIT year-on-year change?
- What is Inozyme Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Inozyme Pharma?
- What is Inozyme Pharma TTM EBIT year-on-year change?
What is Inozyme Pharma annual earnings before interest & taxes?
The current annual EBIT of INZY is -$67.84 M
What is the all time high annual EBIT for Inozyme Pharma?
Inozyme Pharma all-time high annual earnings before interest & taxes is -$11.57 M
What is Inozyme Pharma annual EBIT year-on-year change?
Over the past year, INZY annual earnings before interest & taxes has changed by -$1.04 M (-1.55%)
What is Inozyme Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of INZY is -$23.15 M
What is the all time high quarterly EBIT for Inozyme Pharma?
Inozyme Pharma all-time high quarterly earnings before interest & taxes is -$4.32 M
What is Inozyme Pharma quarterly EBIT year-on-year change?
Over the past year, INZY quarterly earnings before interest & taxes has changed by -$7.47 M (-47.62%)
What is Inozyme Pharma TTM earnings before interest & taxes?
The current TTM EBIT of INZY is -$91.08 M
What is the all time high TTM EBIT for Inozyme Pharma?
Inozyme Pharma all-time high TTM earnings before interest & taxes is -$5.16 M
What is Inozyme Pharma TTM EBIT year-on-year change?
Over the past year, INZY TTM earnings before interest & taxes has changed by -$25.85 M (-39.62%)